Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD

被引：74

作者：

Flood, V. H. ^{[1
]}

Lederman, C. A. ^{[2
]}

Wren, J. S. ^{[3
]}

Christopherson, P. A. ^{[3
]}

Friedman, K. D. ^{[3
]}

Hoffmann, R. G. ^{[4
]}

Montgomery, R. R. ^{[1
,3
]}

机构：

[1] Med Coll Wisconsin, Dept Pediat, Div Hematol Oncol, Milwaukee, WI 53226 USA

[2] Dickstein Canc Ctr, White Plains, NY USA

[3] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA

[4] Med Coll Wisconsin, Dept Pediat, Div Quantitat Hlth Sci, Milwaukee, WI 53226 USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 06期

关键词：

VON-WILLEBRAND-FACTOR; DISEASE; SITE; RISTOCETIN; PLATELETS; ASSAY;

D O I：

10.1111/j.1538-7836.2010.03869.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1431 / 1433

页数：3

共 14 条

[1] von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen [J].

Bonnefoy, A. ;

Romijn, R. A. ;

Vandervoort, P. A. H. ;

Van Rompaey, I. ;

Vermylen, J. ;

Hoylaerts, M. F. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) :2151-2161

[2] AN ELISA TEST FOR THE BINDING OF VONWILLEBRAND ANTIGEN TO COLLAGEN [J].

BROWN, JE ;

BOSAK, JO .

THROMBOSIS RESEARCH, 1986, 43 (03) :303-311

[3] INTERACTION OF THE VON-WILLEBRAND-FACTOR (VWF) WITH COLLAGEN - LOCALIZATION OF THE PRIMARY COLLAGEN-BINDING SITE BY ANALYSIS OF RECOMBINANT VWF A DOMAIN POLYPEPTIDES [J].

CRUZ, MA ;

YUAN, HB ;

LEE, JR ;

WISE, RJ ;

HANDIN, RI .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10822-10827

[4] von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: A 15-year journey [J].

Favaloro, EJ .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (02) :191-202

[5] Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function [J].

Flood, V. H. ;

Friedman, K. D. ;

Gill, J. C. ;

Morateck, P. A. ;

Wren, J. S. ;

Scott, J. P. ;

Montgomery, R. R. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (11) :1832-1839

[6] Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin - but not botrocetin-mediated binding of von Willebrand factor to platelets [J].

Hillery, CA ;

Mancuso, DJ ;

Sadler, JE ;

Ponder, JW ;

Jozwiak, MA ;

Christopherson, PA ;

Gill, JC ;

Scott, JP ;

Montgomery, RR .

BLOOD, 1998, 91 (05) :1572-1581

[7] von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) [J].

Nichols, W. L. ;

Hultin, M. B. ;

James, A. H. ;

Manco-Johnson, M. J. ;

Montgomery, R. R. ;

Ortel, T. L. ;

Rick, M. E. ;

Sadler, J. E. ;

Weinstein, M. ;

Yawn, B. P. .

HAEMOPHILIA, 2008, 14 (02) :171-232

[8]

PARETI FI, 1987, J BIOL CHEM, V262, P13835

[9]

Ribba AS, 2001, THROMB HAEMOSTASIS, V86, P848

[10] Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor [J].

Riddell, Anne F. ;

Gomez, Keith ;

Millar, Carolyn M. ;

Mellars, Gillian ;

Gill, Saher ;

Brown, Simon A. ;

Sutherland, Megan ;

Laffan, Mike A. ;

McKinnon, Thomas A. J. .

BLOOD, 2009, 114 (16) :3489-3496

← 1 2 →